General Information
Version
DRE-C16277000 - Piromidic acid
Revision date
2023-04-05
Product name
Piromidic acid
Substance name
C ₁₄H₁₆N₄O₃ 288.3
CAS No.
19562-30-2
1.2.1 Relevant identified uses
Laboratory use
supplier name
LGC GmbH
Emergency telephone
1-800-424-9300, +493030686700, +1 703-741-5970
Icons in SDS
Company Information
company name
LGC GmbH
e-mail address of the competent person responsible for the Safety Data Sheet
info@lgc-germany.com
GHS Information
Signal word
Danger
Hazard Codes
Hazard statements (CLP)
H317, H334, H361
Hazard statements
Code
Statements
H317
May cause an allergic skin reaction
Section 2
SECTION 2: Hazards identification
Regulation (EC) No. 1272/2008 [CLP]] Classification of the substance or mixture Classification according to
Contains
Piromidic Acid
Signal word
Danger
Hazard statements
H317 - May cause an allergic skin reaction H334 - May cause allergy or asthma symptoms or breathing difficulties if inhaled H361 - Suspected of damaging fertility or the unborn child
Precautionary statements
P261 - Avoid breathing dust/fume/gas/mist/vapours/spray P280 - Wear protective gloves/protective clothing/eye protection/face protection P304 + P340 - IF INHALED: Remove person to fresh air and keep comfortable for breathing P342 + P311 - If experiencing respiratory symptoms: Call a POISON CENTER or doctor P501 - Dispose of contents/ container to an approved waste disposal plant
2.3 Other hazards
No information available. This substance does not meet the PBT/vPvB criteria of REACH, annex XIII. Endocrine Disruptor Information This product does not contain any known or suspected endocrine disruptors. Chemical name
2.1 Classification of the substance or mixture
Classification according to Regulation (EC) No. 1272/2008 [CLP] Respiratory sensitisation Category 1 - (H334) Skin sensitisation Category 1 - (H317) Reproductive toxicity Category 2 - (H361)
